Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.


All category news

  • Takeda proposes sale of Shire drug to gain European approval

    October 29, 2018 7:28 AM 136

    (Reuters) - Takeda Pharmaceutical Co Ltd (4502.T) has proposed to European regulators it could sell a Shire (SHP.L) treatment in development due to concerns of overlap in inflammatory bowel disease treatments and its own drug Entyvio as it seeks clearance for the two companies’ merger. The Japanese drug developer said it had proposed divesting Shire’s

  • NYC reports first pediatric flu death of season

    October 26, 2018 4:29 PM 126

    NEW YORK – Health department officials in New York say a child has died from influenza, the city’s first reported flu-related pediatric death of the season. Acting New York City Health Commissioner Dr. Oxiris Barbot (OHK’-see-rees bahr-BOH’) made the announcement on Thursday. The child’s name, age, gender and borough of residence haven’t been released

  • Hospital accreditation not linked to patient outcomes in U.S

    October 26, 2018 3:03 PM 114

    (Reuters Health) - Hospital accreditation isn’t necessarily tied to better outcomes for U.S. patients, researchers say. Based on records for more than 4.2 million patients over age 65 covered by Medicare, the study team found no difference between accredited and unaccredited hospitals in patient death rates, and only a slightly lower rate of patient

  • U.S. lifts blocks on some fresh, frozen pork imports from Poland

    October 25, 2018 4:28 PM 110

    CHICAGO (Reuters) - The United States has lifted restrictions on some imports of fresh and frozen pork from Poland, specifically from facilities that are in contiguous areas free of the highly contagious hog disease African swine fever, the U.S. Department of Agriculture said Thursday. The ban remains in place on imports of raw and heat-treated pork products

  • Surgeon age doesn't affect cataract surgery outcomes

    October 24, 2018 9:09 PM 116

    (Reuters Health) - Late-career surgeons perform a large proportion of cataract operations, and they do it with an overall low rate of adverse events, a Canadian study suggests. In recent years, researchers have analyzed whether surgeons’ age affects their skills, dexterity and risk for mistakes in the operating room, the study authors note in JAMA Ophthalmology

  • US approves new type of flu drug

    October 24, 2018 7:10 PM 125

    U.S. health regulators have approved the first new type of flu drug in two decades. Wednesday's approval of Xofluza for people age 12 and older comes ahead of the brunt of this winter's flu season. Xofluza is a pill that can reduce severity and shorten duration of flu symptoms after one just dose. It was developed by the Roche Group and Shionogi & Co. It works

  • FDA approves first new flu drug in almost two decades

    October 24, 2018 5:53 PM 135

    (Reuters) - Japan’s Shionogi & Co Ltd and Swiss drugmaker Roche won U.S. Food and Drug Administration (FDA) approval for their flu treatment, the first new flu drug approved by the agency in nearly 20 years. Xofluza was approved to treat acute uncomplicated influenza, a contagious respiratory illness caused by influenza viruses, in patients 12 years

  • Sacramento boy’s wish fulfilled by becoming Ghostbuster

    October 24, 2018 2:02 AM 117

    London Green, now 5, saw "Ghostbusters" when he was just 3 years old -- and he's been obsessed with it ever since. "He'll just come out of whatever room he's in and, 'I got a call!' and then put on his proton pack and go fight ghosts around the house or at the park," Stuart Green, London's dad, told FOX40. "He was born without a pulmonary artery," Green

  • Britain's AstraZeneca to buy 9.8 percent stake in France's Innate Pharma

    October 23, 2018 5:45 AM 126

    PARIS (Reuters) - British drugmaker AstraZeneca will buy a newly issued equity stake of 9.8 percent in smaller French peer Innate Pharma, as consolidation intensifies in the healthcare sector. AstraZeneca will buy the stake via around 6.26 million new shares being issued to it at a price of 10 euros per share, the companies said on Tuesday. Innate Pharma

  • Childhood obesity tied to severe hip disorder

    October 22, 2018 9:31 PM 119

    (Reuters Health) - Kids who are obese may be more likely to develop a severe hip disorder than children who are not overweight, a UK study suggests. The disorder, known as slipped capital femoral epiphysis (SCFE), is one of the most common hip problems in children and adolescents. It can lead the ball at the head of the thigh bone to slip backward and often